Recombinant Columba livia ME1 (partial) refers to a truncated, recombinantly expressed version of the native enzyme. It retains catalytic activity but may lack certain regulatory domains or structural regions present in the full-length protein .
Primary Reaction:
This reaction links glycolysis and the citric acid cycle while supplying NADPH for lipid biosynthesis .
Cofactor Specificity:
Unlike mitochondrial NAD-dependent malic enzymes (ME2), Columba livia ME1 is strictly NADP-dependent. Structural studies highlight key residues (e.g., Lys347) that stabilize NADP binding, a feature conserved across NADP-ME isoforms .
While specific protocols for Columba livia ME1 are not detailed in the provided sources, recombinant production generally follows established methods:
Expression Systems:
Purification:
| Parameter | Typical Conditions |
|---|---|
| Expression Vector | pET-based systems (E. coli) |
| Tag | His-tag at C-terminus |
| Storage | -80°C in Tris buffer with glycerol/DTT |
| Activity Retention | Stable for 12 months at -80°C |
Research on Columba livia ME1 has contributed to understanding malic enzyme evolution and mechanism:
Cofactor Selectivity:
Kinetic Properties:
Recombinant ME1 is utilized in:
Metabolic Studies: Investigating NADPH-dependent pathways in lipid synthesis .
Drug Discovery: Screening for inhibitors targeting cancer metabolism .
Structural Biology: Crystallization studies to resolve mechanisms of cofactor binding .
Unresolved Questions:
Full-length vs. partial enzyme activity differences.
Regulatory roles in avian physiology (e.g., lipid metabolism during flight).
Potential Studies:
Kinetic characterization of the partial enzyme.
Structural comparison with full-length Columba livia ME1.
NADP-dependent malic enzyme (ME1) catalyzes the reversible oxidative decarboxylation of L-malate to produce pyruvate and CO₂ while reducing NADP⁺ to NADPH in the presence of divalent metal ions. This enzyme belongs to a specialized class of oxidative decarboxylases with distinct cofactor preferences. In pigeon liver, ME1 is cytosolic and plays a crucial role in providing NADPH for biosynthetic processes, particularly fatty acid synthesis and desaturation reactions . The reaction catalyzed can be summarized as:
L-malate + NADP⁺ → Pyruvate + CO₂ + NADPH + H⁺
The enzyme shows clear selectivity for NADP⁺ over NAD⁺ as a cofactor, which is important for its biological function in generating reducing power (NADPH) for cellular metabolism .
Recombinant Columba livia ME1 can be expressed in multiple heterologous systems, each offering distinct advantages for research applications:
| Expression System | Product Code Example | Special Features |
|---|---|---|
| Yeast | CSB-YP013634DVK | Post-translational modifications similar to eukaryotes |
| E. coli | CSB-EP013634DVK | High yield, simpler purification |
| In Vivo Biotinylated E. coli | CSB-EP013634DVK-B | Contains Avi-tag for biotinylation via BirA ligase |
| Baculovirus | CSB-BP013634DVK | Insect cell-based expression for complex proteins |
| Mammalian cell | CSB-MP013634DVK | Closest to native eukaryotic processing |
The choice of expression system should be based on experimental requirements, including protein folding needs, post-translational modifications, and downstream applications . For basic enzymatic studies, E. coli-expressed protein often provides sufficient activity, while structural studies may benefit from eukaryotic expression systems that ensure proper folding.
The crystal structure of pigeon cytosolic NADP⁺-dependent malic enzyme has been determined (PDB: 1GQ2) in a closed conformation as a quaternary complex with NADP⁺, Mn²⁺, and oxalate. Key structural features include:
Total molecular weight: approximately 1,016,763.75 Da for the complete structure
Cellular location: Cytoplasm (UniProt: P40927)
Quaternary structure: Contains 16 polymer chains in the crystallographic structure
Cofactor binding: Specific binding site for the 2'-phosphate group of NADP⁺ that defines cofactor selectivity
This structure represents significant information as it was the first structural determination of an NADP⁺-dependent malic enzyme. Despite sequence conservation with other malic enzymes, pigeon ME1 shows substantial structural differences in several regions compared to human NAD⁺-dependent malic enzyme, particularly at the cofactor binding site .
Accurate measurement of ME1 activity requires specific conditions that maximize enzyme function. Based on established protocols, the following optimized reaction system is recommended:
Buffer: 50 mM Tris-HCl, pH 7.5-7.8
Divalent cation: 1 mM MgCl₂ or MnCl₂ (note that Mn²⁺ typically yields higher activity)
Cofactor: 0.5 mM NADP⁺
Substrate: 10 mM L-malate
Temperature: 25-46°C (with maximum activity reported at approximately 46°C for some bacterial NADP-ME)
Detection method: Spectrophotometric measurement at 340 nm to monitor NADPH formation
Activity can be calculated using the formula:
ME activity (U/mg) = [(A₂-A₁) × 6.22 × V₁] / [t × l × V₂ × C]
Where:
A₁ is initial absorbance and A₂ is final absorbance
6.22 is the extinction coefficient for NADPH (mM⁻¹cm⁻¹)
t is reaction time (minutes)
l is cuvette path length (cm)
V₁ is total reaction volume
V₂ is enzyme solution volume
Notable inhibitors include Zn²⁺, which strongly inhibits enzyme activity, making metal ion composition critical for experimental design .
ME1 plays a crucial role in lipid biosynthesis through its NADPH-generating capability. Experimental evidence demonstrates:
Overexpression of ME1 in organisms like Phaeodactylum tricornutum significantly increases neutral lipid content (20-33% increase) and total lipid content (up to 48% increase compared to wild type) .
The enzyme's activity directly correlates with increased NADPH levels, providing reducing power for:
In recombinant systems with altered NADPH production pathways, ME1 activity is upregulated to compensate for NADPH shortages, demonstrating its physiological importance in redox balance .
In studies with bacterial systems, ME1 activity was significantly enhanced (7.83-fold) when switching from glucose to acetate metabolism, particularly in strains with compromised NADPH production, indicating its role in metabolic adaptation .
This evidence points to ME1 as a potential metabolic engineering target for enhanced lipid production in biotechnology applications, as demonstrated by increased saturated fatty acids (23-25%) and PUFAs (49-54%) in transformants overexpressing ME1 .
Several complementary approaches can be employed to investigate structure-function relationships in ME1:
Site-directed mutagenesis: Creating specific amino acid substitutions, particularly at:
Lys362, which appears crucial for NADP⁺ selectivity
Metal-binding residues that coordinate Mn²⁺ or Mg²⁺
Residues in the malate binding pocket
Protein engineering for cofactor specificity:
Altering residues near the 2'-phosphate binding site can potentially modify cofactor preference between NAD⁺ and NADP⁺
Chimeric constructs combining domains from different malic enzymes can reveal functional determinants
Crystallographic analysis:
Enzymatic assays with modified substrates:
Expression of recombinant ME1 with protein tags:
These methodological approaches, when combined, can provide comprehensive insights into the structural basis for ME1's catalytic mechanism, cofactor preference, and regulatory properties.
While ME1's role in lipid metabolism is well-established, the enzyme also serves broader functions in cellular redox homeostasis:
Adaptation to carbon source changes: In bacterial systems, ME1 activity increases dramatically (up to 7.83-fold) when switching from glucose to acetate metabolism, indicating a role in metabolic flexibility .
Compensatory NADPH production: When primary NADPH-generating pathways are compromised (e.g., in engineered strains with NAD-dependent isocitrate dehydrogenase instead of NADP-dependent), ME1 activity is upregulated to maintain NADPH supply .
Growth on two-carbon compounds: ME1 deletion in E. coli strains resulted in poor growth on acetate (only 60% of wild-type growth rate), highlighting its importance for metabolism of certain carbon sources .
Alternative physiological functions: Beyond lipid metabolism, ME has been implicated in:
These diverse functions suggest that ME1 serves as a metabolic node connecting carbon metabolism, redox balance, and stress response, making it an interesting target for both basic research and metabolic engineering applications.
Proper reconstitution of lyophilized recombinant ME1 is critical for maintaining enzymatic activity. The recommended protocol includes:
Initial preparation:
Briefly centrifuge the vial before opening to ensure all material is at the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Storage recommendation:
Add glycerol to a final concentration of 5-50%
Aliquot for long-term storage at -20°C/-80°C to avoid freeze-thaw cycles
Quality control:
Activity verification:
Freshly reconstituted enzyme should be tested for activity using the standard assay conditions
Proper folding can be verified by circular dichroism if structural integrity is a concern
Careful adherence to these reconstitution protocols helps ensure that experimental results with recombinant ME1 are reproducible and reflect the enzyme's native properties.
Several promising research directions exist for further exploration of pigeon ME1:
Comparative structural biology: More detailed comparison between NADP⁺-dependent ME1 from pigeon and NAD⁺-dependent MEs from other organisms could reveal the molecular basis for cofactor selectivity.
Metabolic engineering applications: Building on the demonstrated role of ME1 in enhancing lipid production, engineered ME1 variants with altered regulatory properties could be valuable tools for biotechnology.
Synthetic biology approaches: Designing synthetic metabolic pathways incorporating ME1 could create novel routes for carbon fixation or biofuel production.
Evolutionary studies: Investigating how cofactor preference evolved across different species could provide insights into metabolic adaptation.
Integration with systems biology: Understanding how ME1 functions within the broader metabolic network could reveal new regulatory mechanisms and potential intervention points.